$599

J&J Q1 ’17 Earnings Update

J&J presented its Q1 ’17 earnings results and provided a brief update to its diabetes business including drugs and devices. Of note, J&J is hosting its Pharmaceutical Business Review on May 17.

This content is for Read Less members only.
Register
Already a member? Log in here